MADISON, SD / ACCESS Newswire / June 19, 2025 / Global Polymer, a leading innovator in polymer manufacturing, has unveiled a proprietary new method for custom-molding Ultra High Molecular Weight Polyethylene (UHMW-PE), setting a new industry standard in what is possible with this high-performance material.
Traditionally, UHMW-PE is supplied in sheet form and then fabricated, limiting the design flexibility available to engineers and manufacturers. Global Polymer’s breakthrough process enables the company to custom mold UHMW-PE into complex, high-strength components with varying thicknesses and integrated features, giving OEM companies across various industries new freedom to design for performance, durability, and cost efficiency.
“UHMW-PE is already a game-changing material-offering self-lubricating properties, extreme durability, and resilience across temperature fluctuations,” said Todd Huntimer, President for Global Polymer Industries. “Now, with our proprietary molding technology, we are opening up an entirely new world of design possibilities. We can mold in fasteners, metal inserts, variable wall thicknesses, and geometries that were previously impossible with traditional fabrication methods.”
The new capability is already transforming applications in industries such as:
Forestry Equipment
Car Wash Systems
Marine & Dock Applications
Sewer & Wastewater
Food Processing
Transportation & Material Handling
Agriculture
Oil & Gas
Mining
Manufacturing
With Global Polymer’s technology, engineers can now specify molded UHMW-PE components that perform better, last longer, and simplify assembly without sacrificing the inherent advantages of this versatile polymer.
“This is more than a materials innovation,” added Huntimer. “It’s a manufacturing revolution. We are enabling OEMs to achieve part consolidation, lightweighting, corrosion resistance, and extended wear life with a single custom-molded component.”
The company is actively working with OEM partners to develop custom UHMW-PE solutions that deliver tangible performance and cost benefits.
About Global Polymer Global Polymer is a leading manufacturer specializing in innovative UHMW-PE solutions for demanding applications across a wide range of industries. With its proprietary compression molding technology, the company is redefining what is possible with UHMW-PE-providing engineered components that outperform traditional materials.
BEVERLY HILLS, CA / ACCESS Newswire / June 18, 2025 / World-renowned spinal neurosurgeon and motion preservation expert Dr. Todd H. Lanman will join an elite international faculty at the Total Disc Arthroplasty Masterclass in Amsterdam on June 20, 2025. Dr. Lanman will deliver a series of educational presentations and case-based discussions on the expanding indications for total disc replacement (TDR)-including highly complex cases.
Dr. Lanman, founder of Lanman Spinal Neurosurgery and ADR Spine, will present on challenging lumbar and cervical disc arthroplasty cases, including those involving multilevel degeneration, prior fusions, or advanced pathology. His contributions will spotlight evolving strategies that broaden candidacy for motion-preserving surgery-particularly for patients once limited to spinal fusion. He will also participate in a faculty-led panel discussing revision strategies and clinical decision-making in difficult and multi-level cases.
“We are forging the new age of spinal surgery,” said Dr. Lanman. “With the right technology and expertise, we can now offer motion-preserving solutions to patients who were never considered candidates for disc replacement-patients with prior fusions, complex anatomies, or multilevel disease.”
The Masterclass begins on June 19, 2025, with a dinner and pre-conference case discussions, followed by a full day of expert-led lectures and panels on June 20 at the nhow Amsterdam RAI Hotel. Dr. Todd Lanman will join a distinguished international faculty that includes Dr. Scott Blumenthal (Texas Back Institute), Prof. Dr. Rudolf Bertagnoli (Pro-Spine ECSA, Germany), Dr. Thierry Marnay (CCV Montpellier, France), and Prof. Matthew Scott-Young (Gold Coast Spine, Australia).
Dr. Thierry Marnay will deliver a keynote lecture entitled “What Gives? Why are Spine Surgeons So Far Behind Total Joint Surgeons?” addressing systemic, cultural, and clinical barriers to wider adoption of disc arthroplasty. He will also co-lead participant case discussions, contribute to the session on advanced lumbar case reviews, and serve on the expert faculty panel for complex cervical case analysis
Prof. Matthew Scott-Young will open the Masterclass with a program overview and contribute to case discussions throughout the event. His formal lectures will address cervical disc indications, including motion preservation versus ACDF, and provide an in-depth analysis of cervical disc designs, covering implant materials, mechanical philosophy, and evolving technologies such as fixed versus mobile cores.
Prof. Dr. Rudolf Bertagnoli will present on lumbar complications and revision surgery strategies, including case examples highlighting surgical decision-making in complex revision scenarios. He will also lead sessions on optimizing surgical technique for multilevel cervical arthroplasty and challenging anatomy and participate in interactive discussions on complex cervical cases and disc selection considerations by spinal level.
Dr. Scott Blumenthal will deliver a foundational lecture on lumbar disc arthroplasty, focusing on indications, patient selection, and clinical evidence, as well as considerations for when fusion may still be relevant. He will also lead case discussions on lumbar pathology, and present strategies for cervical revision surgery and participate in the final panel addressing the future of disc arthroplasty.
The Masterclass underscores a growing international consensus that spinal fusion should no longer be the default solution for degenerative disc disease and that total disc arthroplasty is both viable and preferable in an expanding range of cases.
About Dr. Todd H. Lanman
Dr. Todd H. Lanman is a globally recognized spinal neurosurgeon, thought leader, and innovator in motion-preserving spine surgery. With over three decades of clinical experience and more than 25 years in practice in Beverly Hills, he is the founder of Lanman Spinal Neurosurgery and ADR Spine. Dr. Lanman has pioneered numerous surgical firsts in artificial disc replacement (ADR), multilevel arthroplasty, and fusion reversal. He is also a lecturer, educator, and contributor to peer-reviewed publications, advancing the field of spine surgery both academically and in practice.
About Lanman Spinal Neurosurgery
Lanman Spinal Neurosurgery is a leading center for advanced spine care specializing in artificial disc replacement, fusion reversal, and motion preservation. With a focus on restoring full function and range of motion, the practice has been at the forefront of spine health innovation for over 25 years. www.spine.md
About ADR Spine
ADR Spine is a national leader in motion-preserving spinal care, dedicated to advancing the science and practice of artificial disc replacement. Founded by Dr. Todd H. Lanman, ADR Spine is a trusted platform connecting patients with top spine arthroplasty specialists. Through its Top Doctors in Arthroplasty program, ADR Spine rigorously evaluates surgeons based on outcomes, success rates, and clinical expertise. Learn more at www.adrspine.com.
Why Evrima Chicago is Pioneering A11y, Cybersec & Reputation Management for an Aging Digital World
NAPERVILLE, IL / ACCESS Newswire / June 18, 2025 / In a world increasingly dependent on digital access – where aging populations are growing alongside rising cyber threats – Evrima Chicago has positioned itself as a vanguard. Its mission is clear: protect, empower, and elevate older adults and ultra-visible individuals navigating a chaotic digital landscape.
Whether it’s defending a Nobel Peace Prize laureate from impersonation scams, equipping a forensic psychiatrist with secure communications, or ensuring a Pentagon official’s reputation remains intact through a hostile media cycle – Evrima operates at the cutting edge of accessibility, cybersecurity, and elite reputation management.
The Gray Net: Where Aging Meets Digital Vulnerability
By 2050, the global senior population is projected to exceed 2 billion, and the so-called “silver economy” is expected to grow beyond $15 trillion. Despite this staggering market, mainstream tech and cybersecurity firms still under-serve older adults.
That’s where Evrima Chicago steps in. Based in Naperville, Illinois, this firm isn’t just building tools – it’s designing dignity. With assistive technology spanning screen readers, voice-command systems, and immersive virtual reality experiences, Evrima ensures digital inclusion for seniors and individuals with special needs. Accessibility – or A11y – isn’t a feature. It’s their foundation.
When Cybercrime Crosses Generational Lines
Older adults lost more than $3.4 billion to cybercrime in 2023, with the most at-risk individuals including not just everyday retirees – but aging professionals such as lawyers, doctors, and former intelligence officers. These individuals require a new kind of protection: stealth-class cyber defense.
Evrima combats these threats with military-grade protocols, behavioral threat modeling, and deep reputational shielding. These tools protect not only sensitive data but entire digital identities – ensuring clients maintain control over their legacy, their public image, and their Google footprint.
Digital Armor for the Ultra-Visible
High-profile individuals don’t just need public relations – they need precision digital control. One deepfake, misquote, or misinformation campaign can derail a lifetime of credibility.
Evrima Chicago offers “reputation sovereignty” by managing Knowledge Panels, Wikipedia entries, and search visibility – well before crises emerge.
Whether it’s a bestselling author, a reclusive investor, or a national figure preparing for confirmation hearings, Evrima’s team ensures the digital battlefield is secured in advance.
Journalism Without Strings: The Evrima Newsroom Model
Unlike most PR firms, Evrima Chicago operates a bias-free, ad-free newsroom. This editorial independence ensures that clients are featured in credible, citation-ready content – no pay-to-play gimmicks, no vanity press.
Their publishing model delivers real authority. With data-backed storytelling and syndication-ready releases, policy influencers and public figures can shape their digital narrative proactively, not reactively.
The Evrima Ethos: Serve the Person, Secure the Legacy
Evrima Chicago isn’t just building technology – it’s building trust in an era where both are in short supply. From octogenarian activists to billionaires in the twilight of their careers, the firm delivers services designed for an aging digital elite.
This is not public relations as usual. This is cyber guardianship. This is reputation sovereignty. This is the future of digital dignity.
Glossary
Assistive Technology (AT): Tools that help individuals with disabilities or age-related limitations live independently – such as screen readers, VR mobility simulations, and adaptive input devices.
A11y: A numeronym for “accessibility” (A + 11 letters + Y), emphasizing inclusive design for users of all ages and abilities.
UHNW: Ultra-high-net-worth individuals with over $30 million in assets, who frequently face heightened cybersecurity and reputational risks.
At Evrima Chicago, the mission is simple but essential:
“A safer, more inclusive digital world – one elder, one executive, one encrypted connection at a time.”
Who is Waa Say?
Waa Say is the caffeinated compass of the Evrima Chicago newsroom – its Editor-in-Chief, chief mischief-maker, and occasional fire extinguisher when headlines get too hot to handle. With a pen sharper than a Senate filibuster and a filing cabinet full of Post-it provocations, Waa Say doesn’t just write stories – he orchestrates editorial ambushes on mediocrity. Working closely with Chicago Bureau Chief Mr. Ovais Riaz, he steers coverage with a blend of literary flair and old-school newsroom grit.
In an America where politics feels like reality TV with fewer writers and worse wardrobe choices, Waa Say finds clarity in chaos. He’s the guy who’ll quote both Baldwin and Bugs Bunny before a deadline, reminding readers that truth needs teeth-and sometimes a punchline.
Disclaimer
This article was produced by Evrima Chicago LLC for editorial and informational purposes. The views expressed are drawn from cited sources and do not necessarily reflect the positions of any government, agency, or client. For inquiries, contact pr@evrimachicago.com or waasay@evrimachicago.com.
Sources and Citations
Source
Details
AARP (2021)
Technology Trends Among Older Adults – AARP Research Report
HOUSTON, TX / ACCESS Newswire / June 18, 2025 / Epique Realty, one of the fastest-growing brokerages in the nation, has announced a groundbreaking partnership with Courted, the award-winning agent attraction and retention platform. This revolutionary alliance will provide every Epique agent with full access to Courted’s advanced technology – an unprecedented move that sets a new standard for agent empowerment across the real estate industry.
At a time when Epique Realty is rapidly expanding across the country and changing lives with its agent-first philosophy, this partnership supercharges that mission with best-in-class AI-powered recruiting intelligence, personalized retention insights, and market visibility tools once only reserved for executive leadership. Now, all Epique agents – no matter where they are – will have the same level of market data and strategic insight once limited to the top floor.
“We’re excited to partner with Epique Realty, a company that shares our vision for agent empowerment through smart, data-driven solutions,” said Sean Soderstrom, Co-Founder and CEO of Courted. “Epique’s decision to provide Courted to all agents is a forward-thinking investment in agent success, scalability, and a bold competitive play. This partnership is a testament to Epique’s pursuit of innovation – not just to drive immediate results but to create a platform for long-term growth through agent attraction.”
Soderstrom added: “Our ability to drive growth for a cloud-based brokerage by equipping its agents and teams with powerful tools is made possible by the rapidly expanding functionality of the Courted platform. We started as an AI-native company, and that foundation has proven essential as we harness today’s pace of innovation across our structured and proprietary data sets.”
This partnership reflects Epique’s relentless commitment to creating an unmatched experience for its agents – delivering extraordinary value, powerful technology, and unlimited opportunities at no cost to them. Through Courted, Epique agents will gain predictive insights into local market movements, AI-powered outreach tools, and visibility into agent migration trends – making it easier than ever to build and grow high-performing teams.
Joshua Miller, CEO and Co-Founder of Epique Realty, shared: “Our partnership with Courted isn’t just a tech integration, it’s a massive leap forward in our mission to revolutionize real estate from the inside out. We believe agents deserve every advantage to succeed, and Courted gives our people the data, insight, and reach to grow smarter and faster. This is what happens when innovation meets intention.”
Janice Delcid, CFO and Co-Founder of Epique Realty, added: “At Epique, we invest in people first. That’s what makes this partnership so aligned with our values. Courted amplifies our ability to support agents with tools that build sustainable businesses, create deeper connections, and foster long-term growth. It’s not just a win for our agents – it’s a win for the communities they serve.”
Christopher Miller, COO and Co-Founder of Epique Realty, stated: “This is more than access to data – it’s an agent’s gateway to transformation. With Courted, our agents can identify, connect, and collaborate like never before. It’s a strategic advantage that levels the playing field and raises the bar. We’re building something profoundly different at Epique – and this is a bold step forward.”
This move makes Epique the first real estate company to deploy Courted at scale for its entire agent community – solidifying its role as a trailblazer in AI innovation, agent growth, and culture-first leadership. Together, Epique and Courted are rewriting the rules of real estate – equipping agents with the power to own their future, grow their businesses, and attract like-minded leaders into a thriving community.
This is the future. And at Epique, the future is already here.
About Courted Courted is the leading recruiting and retention platform for residential real estate brokerages. Designed to help companies grow smarter, Courted uses proprietary predictive analytics and production data to help brokerages identify, engage, and convert top agent talent – and retain their best performers.
Epique Realty is a trailblazing, agent-first real estate brokerage committed to empowering its agents through a comprehensive suite of free resources and benefits including extraordinary support, award-winning AI technology, and a culture of radical generosity that fuels agent success. By questioning industry norms and putting agents at the center of its universe, Epique is not just transforming the real estate market – it is defining the future. #BeEpique
Acclaimed entrepreneur and tech trailblazer join the team shaping Canada’s leading innovation events
TORONTO, ON / ACCESS Newswire / June 18, 2025 / Elevate, the non-profit organization behind Canada’s most influential tech and innovation festival, is pleased to announce that Arlene Dickinson and Amber Mac have joined its Advisory Board. Dickinson, Founder of District Ventures Capital and a longtime Dragon, is one of Canada’s most respected entrepreneurs. Mac is a tech and media trailblazer, President of award-winning content development agency AmberMac Media.
Elevate CEO and Co-Founder, Lisa Zarzenczny, welcomes these powerhouse leaders as the organization gears up for its seventh annual Elevate Festival (October 7-9, 2025) in Toronto, which will bring together over 250 speakers and 10,000 attendees from across the global tech community. This year’s Main Stage will touch on applied AI to revolutionize customer experiences, autonomous transportation, and personalized health insights, among many other content themes and program offerings. The Festival has a track record of catalyzing hundreds of thousands of dollars in startup investments and leads in the industry in gender diversity. The organization also hosts CIX Summit and year-round Elevate Innovation programs to help Canadian founders build their businesses.
“I’ve spent my life in venture capital and marketing helping entrepreneurs and organizations grow their businesses and their dreams,” said Arlene Dickinson. “It’s never been more important to support Canadian innovation and invest in our collective future. I’m happy to join Elevate to help advance this mission.”
“Elevate has made a significant impact in growing the local innovation ecosystem, and I’m proud to help them accelerate their next chapter,” said Amber Mac. “Canada is emerging as an AI superpower but we need to work together to achieve a better digital future for all.”
Dickinson and Mac join current board members:
Christopher Wein, Chief Operating Officer, Equiton Development;
Debbie Gamble, Group Head, Strategy & Marketing, Interac;
Rizwan Khalfan, EVP, Canadian Personal Banking Digital, TD;
Salim Teja, Partner, Radical Ventures.
About Arlene Dickinson
Arlene Dickinson is the Founder and General Partner of District Ventures Capital, a VC fund investing in innovative companies that are transforming the way we live and eat. She is widely recognized for her role as a Venture Capitalist on Dragons’ Den, where she has starred for over 17 seasons, and is a three-time bestselling author.
About Amber Mac
Amber Mac is President of AmberMac Media, Inc., an award-winning content development agency, and host of The AmberMac Show podcast on SiriusXM. She was named one of DMZ’s Women of the Year in 2024 and is a bestselling author of multiple books including the Amazon bestseller, Outsmarting Your Kids Online.
About Elevate
Elevate is a Canadian non-profit that unites world-class innovators to catalyze transformation in the Canadian tech ecosystem. Through year-round programs and events, including the annual Elevate Festival and CIX Summit, Elevate shines a spotlight on Canadian innovation, facilitates global connections with startups and investors, and inspires Canadians to embrace a go-for-gold mentality to help shape the future of the Canadian innovation economy.
Media Contact: Amanda Connon-Unda Senior Director of Marketing, Elevate amanda@elevate.ca
GoodData recognized by Gartner® for ability to execute and completeness of vision.
SAN FRANCISCO, CA / ACCESS Newswire / June 18, 2025 / GoodData, the AI-native analytics platform, today announced its inclusion in the 2025 Gartner® Magic Quadrant™ for Analytics and Business Intelligence Platforms. Recognized as a Niche Player, GoodData was acknowledged for its ability to execute and completeness of vision.
At the core of GoodData’s platform is its composability strategy, powered by open source technology, multi-tenancy framework, and an open semantic layer, giving data teams the ability to define metrics once and reuse them across every dashboard, application, or tool in the enterprise. This ensures consistent, governed insights at scale while aligning analytics with business logic and objectives.
“GoodData was built for a world where analytics isn’t a nice-to-have. It is a critical part of the enterprise data landscape, and we believe that our inclusion in the Gartner Magic Quadrant is a testament to the demand for interoperable analytics platforms that treat analytics as code and fit seamlessly into the modern DevOps and product development lifecycle.”
Roman Stanek, CEO and Founder of GoodData.
With its analytics-as-code approach, GoodData enables development teams to build and extend data experiences like any other software component. This empowers teams to automate development with CI/CD pipelines, fully customize the user experience through APIs and embedded components, and ensure trust in the data through automated testing and version control.
Additionally, GoodData’s commitment to interoperability sets it apart. Native features like FlexConnect and metadata ingestion from third-party BI tools allow teams to unify data across silos and ecosystems without duplicating or moving data. The platform’s zero-copy architecture enhances performance while maintaining data integrity and governance.
“GoodData’s flexibility to integrate into any backend setup has proven to provide maximum flexibility for our engineering needs.”
VP, Product in the Banking sector; from Gartner® Peer Insights™ review
“The future of BI is not in monolithic dashboards – it’s in flexible, embedded, and governed insights that live where decisions are made. By focusing on analytics-as-code and end-to-end composability, we’re equipping data and product teams with the tools they need to innovate faster and smarter.”
Ryan Dolley, VP of Product Strategy at GoodData
In our opinion, GoodData’s position in the Magic Quadrant underscores a market shift toward developer-centric analytics platforms that seamlessly integrate into today’s complex data stacks and product environments. Read the full Gartner® Magic Quadrant™ report to see a complete analysis of GoodData’s strengths and cautions.
GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant and Peer Insights are a registered trademark, of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences with the vendors listed on the platform, should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About GoodData
GoodData is the AI-native analytics platform built for speed, scale, and trust, helping companies deliver real-time insights – embedded, branded, and everywhere your users need them.
Founded in 2007, and with offices in both the U.S. and Europe, GoodData serves over 140,000 of the world’s top companies and 3.2 million users, helping them drive meaningful change and maximize the value of their data.
Study used cell lines obtained from the Progeria Research Foundation to evaluate Telomir-1’s effects on key drivers of accelerated aging
MIAMI, FLORIDA / ACCESS Newswire / June 18, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a preclinical-stage biotechnology company focused on reversing biological aging and age-related diseases, today announced compelling new preclinical data showing that its lead candidate, Telomir-1, prevented cellular aging in human progeria cell lines obtained from the Progeria Research Foundation. Progeria, or Hutchinson-Gilford Progeria Syndrome (HGPS), is an ultra-rare pediatric disorder caused by a mutation in the LMNA gene. This mutation results in the production of an abnormal protein called progerin, which drives rapid biological aging in children.
There are an estimated 400-500 known cases worldwide, including fewer than 30 children currently living with the disease in the United States. Symptoms typically begin within the first two years of life and include growth failure, joint stiffness, loss of body fat and hair, and severe cardiovascular disease. Children with progeria have an average life expectancy of just 13 to 15 years, with most dying from heart attacks or strokes at a young age.
The only FDA-approved therapy for progeria, Zokinvy® (lonafarnib), is a farnesyltransferase inhibitor that has been shown to extend lifespan by an average of 4.3 years. However, Zokinvy does not reverse the underlying disease pathology or halt cardiovascular deterioration, which remains the leading cause of death. No approved therapy restores normal cell function or reverses the biological hallmarks of accelerated aging in progeria, highlighting a significant and urgent unmet medical need.
Telomir-1 is designed to regulate intracellular metal ions, reduce oxidative stress, restore mitochondrial function, extend telomere length, reverse muscle loss, and reset age-associated DNA methylation patterns – all of which are critical biological pathways implicated in progeria and broader age-related diseases.
In this study, conducted by Smart Assays, Telomir-1 was tested in cells taken directly from a child with HGPS. These cells were obtained from The Progeria Research Foundation (www.progeriaresearch.org). The study evaluated cell viability, reactive oxygen species (ROS), and intracellular calcium signaling – a marker of mitochondrial dysfunction – under both normal and stress-induced conditions.
Key findings include:
Improved cell viability: Telomir-1 increased survival in a dose-dependent manner, both under basal conditions and even under stress conditions induced by copper and iron-two metal ions known to accelerate aging by generating oxidative damage and destabilizing DNA and telomeres.
Reduction of oxidative stress: Progeria cells exhibited abnormally high levels of reactive oxygen species (ROS), a hallmark of cellular aging. Telomir-1 normalized these levels, both under basal conditions and even when ROS was further elevated by toxic metal exposure.
Restoration of mitochondrial function: Iron-induced calcium overload – a signal of mitochondrial damage and a known feature of HGPS – was significantly reduced with Telomir-1, indicating restored mitochondrial regulation and improved cellular energy balance.
These results demonstrate that Telomir-1 directly addresses the core cellular dysfunctions driving disease features in progeria – not only protecting cells from damage but restoring critical biological functions. The fact that these results were observed in actual patient-derived human cells offers strong early validation of Telomir-1’s therapeutic potential.
“These results provide the strongest evidence to date that Telomir-1 is not only protective but also restorative at the molecular and cellular level,” said Dr. Angel, Chief Scientific Advisor of Telomir. “What’s especially promising is that the improvements we observed directly target the mechanisms known to drive disease progression in progeria – oxidative stress, metal toxicity, and mitochondrial instability. This level of functional rescue in actual patient-derived cells is highly encouraging as we move toward clinical translation. These studies come as further validation of the very promising results obtained previously in both nematode and zebrafish models of adult progeria.”
“These findings deepen our conviction that Telomir-1 can be a first-in-class therapeutic platform for rare aging syndromes and broader age-related diseases,” said Erez Aminov, CEO of Telomir. “By demonstrating the ability to reverse cellular damage in human progeria cells, Telomir-1 represents a potential breakthrough for children who currently have no real options beyond modestly delaying the inevitable. This work also lays the foundation for broader applications in neurodegeneration, metabolic dysfunction, and systemic aging.
The new data also build on previously reported studies in zebrafish and C. elegans nematodes harboring the wrn gene mutation (a model of adult progeria, or Werner syndrome), where Telomir-1 significantly extended lifespan, restored telomere length, reversed muscle degeneration, and normalized molecular age markers.
Telomir is currently finalizing IND-enabling studies for Telomir-1 and plans to engage with the U.S. Food and Drug Administration (FDA) to explore regulatory pathways, including the potential for orphan drug designation. The company is evaluating multiple rare disease indications for initial clinical development.
This press release, statements of Telomir’s management or advisors related thereto, and the statements contained in the news story linked in this release contain “forward-looking statements,” which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These risks and uncertainties include, but are not limited to, the potential use of the data from our studies, our ability to develop and commercialize Telomir-1 for specific indications, and the safety of Telomir-1.
Any forward-looking statements in this press release are based on Telomir’s current expectations, estimates and projections only as of the date of this release. These and other risks concerning Telomir’s programs and operations are described in additional detail in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which are on file with the SEC and available at www.sec.gov. Telomir explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.
SIOUX FALLS, SD / ACCESS Newswire / June 18, 2025 / Avel eCare, a leading provider of telemedicine services, today announced a strategic partnership with Alliant Purchasing, one of the nation’s largest independent Group Purchasing Organizations (GPOs), to bring innovative virtual care solutions to more than 35,000 healthcare provider organizations across the U.S.
Through this partnership, Alliant Purchasing members, including rural and urban hospitals, clinics, and long-term care facilities, will gain preferred pricing and streamlined access to Avel eCare’s full suite of 10 virtual service lines. The services are designed to help address critical healthcare challenges, including clinical staffing shortages, the need to keep care local, and the ongoing demand for high-quality, affordable care across the healthcare continuum.
“We are excited to bring Avel’s expertise and services to our members,” said Kary LeBlanc, COO of Alliant Purchasing. “Avel’s telemedicine solutions offer an important opportunity for our members, particularly those in rural communities, to expand access to care while improving outcomes and addressing staffing challenges. By integrating Avel into our vendor options, Alliant members now have a seamless and cost-effective path to virtual care implementation.”
Under the partnership, Alliant Purchasing members will have preferred access and pricing on Avel’s extensive telemedicine service portfolio:
Emergency
Hospitalist
Pharmacy
Behavioral Health
ICU (Critical Care)
Virtual Nursing
School Health
EMS Support
Senior Care
“This partnership directly supports Avel’s mission of helping healthcare providers-large and small-thrive in today’s challenging environment,” said Doug Duskin, CEO of Avel eCare. “Together, we are empowering providers to meet growing patient needs, improve care quality, and ease the burden on overstretched clinical teams. This is especially vital for rural hospitals, where staffing shortages often threaten the ability to keep care local.”
Avel’s services are backed by more than 30 years of clinical and telemedicine innovation, providing 24/7 access to board-certified specialists and delivering proven results.
About Alliant Purchasing For more than 30 years, Alliant Purchasing has served a diverse group of healthcare providers nationwide. Originally conceived by a large urban healthcare system to assist small rural hospital partners, Alliant continues its tradition of combining divergent interests to create collective value. Today, Alliant serves more than 230 hospital members and over 35,000 members and leverages more than $84 billion in buying power to simplify the healthcare supply chain and provide transformational value. For more information, visit https://www.alliantpurchasing.com
About Avel eCare Avel eCare is a national leader in technology enabled clinical services delivered through telemedicine, delivering provider-to-provider virtual care solutions that expand clinical capacity and improve outcomes across the healthcare industry. With more than 30 years of innovation, Avel’s board-certified clinicians’ partner with hospitals, clinics, long-term care facilities, schools, EMS agencies, and correctional health systems nationwide to bring high-quality care to patients when and where it’s needed most. Learn more at: www.avelecare.com
NEW YORK CITY, NY / ACCESS Newswire / June 18, 2025 / Vero Technologies is pleased to announce its participation in the 2025 NIADA Convention & Expo, the premier annual gathering for the independent automobile dealer industry, taking place June 23-26 at the Fontainebleau Las Vegas.
CEO and Co-Founder John Mizzi and VP of Partnerships Jason Bartz will represent the company at the convention. Together, they’ll engage with specialty finance companies, auctions, and other lenders who provide critical financing solutions to independent dealers nationwide.
The NIADA Convention & Expo brings together thousands of independent automobile dealers and industry partners for four days of education, networking, and innovation. As the largest event in the independent auto industry, it provides an unparalleled platform for meaningful connections between dealers and the financial partners who support their businesses.
“Independent dealers are a critical part of the retail automotive ecosystem, and the lenders behind them often work with aging systems that create more friction than value,” said John Mizzi, CEO of Vero Technologies. “We’re looking forward to hearing firsthand how these providers are thinking about scale, compliance, and risk, and sharing how a modular approach like VeroOS can help streamline their day-to-day without disrupting what already works.”
Vero’s attendance at NIADA underscores the company’s focus on empowering lenders who serve the independent auto market. The convention will provide opportunities to explore how Vero’s technology platform can help these financial partners streamline their operations, reduce costs, and deliver superior service to their dealer customers.
About NIADA
The National Independent Automobile Dealers Association (NIADA) is among the nation’s largest trade associations, representing the used motor vehicle industry comprised of over 40,000 licensed dealers. Since 1946, NIADA has represented the voice and interests of used car dealers at the federal level in Washington D.C. Learn more at www.niada.com.
About Vero Technologies
Vero Technologies is a leading financial technology platform for asset finance, providing end-to-end solutions for wholesale finance, trade finance, equipment finance, and title management. Vero’s modular platform enables lenders to streamline loan servicing, risk monitoring, and operational workflows – enhancing efficiency while reducing costs.
RALEIGH, NC / ACCESS Newswire / June 18, 2025 / iAccess Alpha’s Virtual Best Ideas Summer Investment Conference will take place on June 24-25, 2025, bringing together top micro-cap companies and investors for two days of high-quality insights and investing opportunities.
The event begins on Tuesday, June 24, 2025, with a series of live-streamed company presentations, beginning at 9:00 AM ET. The following day, Wednesday, June 25, will be dedicated to 1×1 meetings between presenting companies and investors, starting at 8:00 AM ET.
How to Attend:
Investors and industry professionals can register to watch the presentations and request 1×1 meetings by visiting the official event website: Register Here
Conference Schedule – June 24, 2025 (All Times ET):
About iAccess Alpha’s Virtual Best Ideas Investment Conferences
iAccess Alpha hosts four virtual investment conferences annually (March, June, September, and December), showcasing high-potential small and micro-cap investment opportunities. The conferences feature live company presentations on Day 1, followed by exclusive 1×1 investor meetings on Day 2. Since 2019, iAccess Alpha has co-organized leading microcap-focused events, connecting top-tier investors with high-potential companies.
